Colin G. Edwards

1.7k total citations
20 papers, 1.2k citations indexed

About

Colin G. Edwards is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Colin G. Edwards has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Genetics. Recurrent topics in Colin G. Edwards's work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Colin G. Edwards is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Colin G. Edwards collaborates with scholars based in United States and Sweden. Colin G. Edwards's co-authors include Clara D. Bloomfield, Andrew J. Carroll, Richard A. Larson, Krzysztof Mrózek, Robert J. Mayer, Amy S. Ruppert, Mark J. Pettenati, Guido Marcucci, Joseph O. Moore and Jonathan E. Kolitz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Psychiatry.

In The Last Decade

Colin G. Edwards

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin G. Edwards United States 13 943 426 402 279 111 20 1.2k
Dimitrios Margaritis Greece 11 246 0.3× 147 0.3× 26 0.1× 138 0.5× 80 0.7× 36 598
Bruno Schratzenstaller Germany 6 391 0.4× 162 0.4× 32 0.1× 103 0.4× 172 1.5× 9 600
Joseph Maly United States 11 245 0.3× 164 0.4× 36 0.1× 89 0.3× 176 1.6× 31 604
Annalisa Andreoli France 12 154 0.2× 71 0.2× 49 0.1× 109 0.4× 43 0.4× 17 376
Mehreen Ali Khan Pakistan 12 96 0.1× 105 0.2× 79 0.2× 144 0.5× 41 0.4× 37 459
Valeria Bozzi Italy 16 585 0.6× 114 0.3× 13 0.0× 173 0.6× 42 0.4× 28 821
Deb Colville Australia 16 126 0.1× 313 0.7× 36 0.1× 61 0.2× 16 0.1× 43 971
Lulin Choubtum Thailand 11 124 0.1× 69 0.2× 79 0.2× 161 0.6× 53 0.5× 22 454
J. A. Leeuw Netherlands 12 78 0.1× 124 0.3× 125 0.3× 16 0.1× 143 1.3× 17 528
Elaine Y. Chiang United States 11 300 0.3× 93 0.2× 16 0.0× 275 1.0× 20 0.2× 15 733

Countries citing papers authored by Colin G. Edwards

Since Specialization
Citations

This map shows the geographic impact of Colin G. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin G. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin G. Edwards more than expected).

Fields of papers citing papers by Colin G. Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin G. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin G. Edwards. The network helps show where Colin G. Edwards may publish in the future.

Co-authorship network of co-authors of Colin G. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Colin G. Edwards. A scholar is included among the top collaborators of Colin G. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin G. Edwards. Colin G. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edwards, Colin G., et al.. (2024). The antimicrobial effectiveness of chlorhexidine and chlorhexidine-silver sulfadiazine-impregnated central venous catheters against the emerging fungal pathogen Candida auris. American Journal of Infection Control. 52(11). 1283–1288. 3 indexed citations
2.
Fisher, James L., David Pettersson, Judith Schwartzbaum, et al.. (2014). Loud Noise Exposure and Acoustic Neuroma. American Journal of Epidemiology. 180(1). 58–67. 30 indexed citations
3.
Prochazka, Michaela, Maria Feychting, Anders Ahlbom, et al.. (2010). Occupational exposures and risk of acoustic neuroma. Occupational and Environmental Medicine. 67(11). 766–771. 16 indexed citations
4.
5.
6.
Edwards, Colin G., Judith Schwartzbaum, Gun Nise, et al.. (2007). Occupational Noise Exposure and Risk of Acoustic Neuroma. American Journal of Epidemiology. 166(11). 1252–1258. 26 indexed citations
7.
8.
Lozanski, Gerard, Ben L. Sanford, Daohai Yu, et al.. (2006). CD52 Expression in Adult Acute Lymphoblastic Leukemia (ALL): Quantitative Flow Cytometry Provides New Insights.. Blood. 108(11). 2293–2293. 3 indexed citations
9.
Edwards, Colin G., Judith Schwartzbaum, Stefan Lönn, Anders Ahlbom, & Maria Feychting. (2005). Exposure to Loud Noise and Risk of Acoustic Neuroma. American Journal of Epidemiology. 163(4). 327–333. 44 indexed citations
10.
11.
Marcucci, Guido, Claudia D. Baldus, Michael D. Radmacher, et al.. (2005). Overexpression of the ERG Gene Is an Adverse Prognostic Factor in Acute Myeloid Leukemia (AML) with Normal Cytogenetics (NC): A Cancer and Leukemia Group B Study (CALGB).. Blood. 106(11). 335–335. 2 indexed citations
12.
13.
Marcucci, Guido, Krzysztof Mrózek, Amy S. Ruppert, et al.. (2005). Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study. Journal of Clinical Oncology. 23(24). 5705–5717. 265 indexed citations
14.
Marcucci, Guido, Claudia D. Baldus, Amy S. Ruppert, et al.. (2005). Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study. Journal of Clinical Oncology. 23(36). 9234–9242. 160 indexed citations
15.
Byrd, John C., Amy S. Ruppert, Krzysztof Mrózek, et al.. (2004). Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461. Journal of Clinical Oncology. 22(6). 1087–1094. 156 indexed citations
16.
Mrózek, Krzysztof, Andrew J. Carroll, Kati Maharry, et al.. (2004). Central Review of Cytogenetics Is Essential for Cooperative Group Clinical and Correlative Studies of Acute Leukemia: The Cancer and Leukemia Group B (CALGB) 8461 Experience.. Blood. 104(11). 1081–1081. 3 indexed citations
17.
18.
Mrózek, Krzysztof, Thomas W. Prior, Colin G. Edwards, et al.. (2001). Comparison of Cytogenetic and Molecular Genetic Detection of t(8;21) and inv(16) in a Prospective Series of Adults With De Novo Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study. Journal of Clinical Oncology. 19(9). 2482–2492. 79 indexed citations
19.
Byrd, John C., Richard K. Dodge, Andrew J. Carroll, et al.. (1999). Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered. Journal of Clinical Oncology. 17(12). 3767–3775. 224 indexed citations
20.
Gallant, Donald M., Colin G. Edwards, M. P. BISHOP, & Gary C. Galbraith. (1964). WITHDRAWAL SYMPTOMS AFTER ABRUPT CESSATION OF ANTIPSYCHOTIC COMPOUNDS: CLINICAL CONFIRMATION IN CHRONIC SCHIZOPHRENICS. American Journal of Psychiatry. 121(5). 491–493. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios Margaritis Breakdown of academic impact, for papers by Bruno Schratzenstaller Breakdown of academic impact, for papers by Joseph Maly Breakdown of academic impact, for papers by Annalisa Andreoli Breakdown of academic impact, for papers by Mehreen Ali Khan Breakdown of academic impact, for papers by Valeria Bozzi Breakdown of academic impact, for papers by Deb Colville Breakdown of academic impact, for papers by Lulin Choubtum Breakdown of academic impact, for papers by J. A. Leeuw Breakdown of academic impact, for papers by Elaine Y. Chiang
Rankless by CCL
2026